ORBIT

Research project ORBIT II

Expansion of a highly efficient trickle bed bioreactor and optimization of the methanation plant for commercial industrial use

Official launch of the trial operation of the ORBIT bioreactor

The trickle bed bioreactor, the centerpiece of the ORBIT project, was put into operation at the OTH Regensburg. On May 15th 2019, the plant was presented on site during a press conference.

The research project “ORBIT – Optimization of a Trickle Bed Bioreactor for the Dynamic Microbial Biosynthesis of Methane with Archaea in Power-to-Gas Plants”, funded by the German Federal Ministry for Economic Affairs and Energy (BMWi), has been working on biological methanation since July 2017.

Following the relocation of the trickle bed reactor at the beginning of March and intensive work on the research facility, the entire system was commissioned on May 15th. Following successful technical testing at FAU Erlangen-Nuremberg, archaea can now be inoculated for the first time and the conversion of carbon dioxide and hydrogen to methane can be tested.

Under the eyes of press representatives and visitors, the OTH network coordinators Prof. Dr. Michael Sterner and Martin Thema, together with the project partners, presented the power-to-gas research facility. Among others, Dr. Anett Bellack from the University of Regensburg, Prof. Dr. Jürgen Karl and Tobias Weidlich from FAU Erlangen-Nuremberg, and Dr. Doris Hafenbradl from Electrochaea GmbH went into detail about the various components of the plant. 

You can read more about the ORBIT project in the official press release of the OTH Regensburg or in the following articles:

Authors: FENES, Michael Heberl

V.l.n.r.: Dr. Annett Bellack (Universität Regensburg), Martin Thema, Prof. Dr. Michael Sterner, Präsident Prof. Dr. Wolfgang Baier (alle OTH Regensburg), Prof. Dr. Jürgen Karl, Tobias Weidlich (beide FAU Erlangen-Nürnberg) und Dr. Doris Hafenbradl (Electrochaea GmbH) bei der Pressekonferenz an der OTH Regensburg. Foto: OTH Regensburg / Florian Hammerich
From left to right: Dr. Annett Bellack (University of Regensburg), Martin Thema, Prof. Dr. Michael Sterner, President Prof. Dr. Wolfgang Baier (all from the OTH Regensburg), Prof. Dr. Jürgen Karl, Tobias Weidlich (both the FAU Erlangen-Nuremberg) and Dr. Doris Hafenbradl (Electrochaea GmbH) at the press conference at OTH Regensburg. Photo: OTH Regensburg / Florian Hammerich
Dr. Annett Bellack beim Animpfen mit Archaean an der ORBIT-Anlage. Foto: OTH Regensburg / Florian Hammerich
Dr. Annett Bellack inoculating the archea at the ORBIT facility. Photo: OTH Regensburg / Florian Hammerich
V.l.n.r.: Prof. Dr. Michael Sterner (OTH Regensburg), Tobias Weidlich (FAU Erlangen-Nürnberg), Dr. Doris Hafenbradl (Electrochaea GmbH), Dr. Annett Bellack (Universität Regensburg) und Martin Thema (OTH Regensburg) vor dem Rieselbett-Bioreaktor. Foto: OTH Regensburg / Florian Hammerich
From left to right: Prof. Dr. Michael Sterner (OTH Regensburg), Tobias Weidlich (FAU Erlangen-Nuremberg), Dr. Doris Hafenbradl (Electrochaea GmbH), Dr. Annett Bellack (University of Regensburg) and Martin Thema (OTH Regensburg) in front of the trickle bed bioreactor. Photo: OTH Regensburg / Florian Hammerich